Cite
HARVARD Citation
Julien, K. et al. (2020). Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment‐Related Adverse Events From the CheckMate 040 Study. Oncologist. pp. e1532-e1540. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Julien, K. et al. (2020). Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment‐Related Adverse Events From the CheckMate 040 Study. Oncologist. pp. e1532-e1540. [Online].